Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
about
Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsyWhen prostate cancer remains undetectable: The dilemmaCUA guidelines on prostate biopsy methodology.Characterization of prostate cancer detected at repeat biopsy.Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection.Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.Beyond diagnosis: evolving prostate biopsy in the era of focal therapy.Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy.Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.Saturation biopsy for detecting and characterizing prostate cancer.Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomySaturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy.Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort studyLow incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy.Release of Cell-free MicroRNA Tumor Biomarkers into the Blood Circulation with Pulsed Focused Ultrasound: A Noninvasive, Anatomically Localized, Molecular Liquid Biopsy.Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy.Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice.The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancerSignificance of atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in prostate biopsy.Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.Limitations of a contemporary prostate biopsy: the blind march forward.Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm.
P2860
Q24648547-6D8E87AD-BA7B-4BA6-9127-53F1452DD1ADQ26795515-B23EA19E-B5B4-4976-AE6A-BF6803B46B00Q30482174-7EE6AA22-D6C8-4410-B0C6-7E1A79ECA1A4Q33383643-D4F1A41D-2A77-4963-AD32-641412D3C20EQ33863562-74B64857-EB5D-4E6B-AF0F-BCEA3A6059AFQ34035596-7C6E2FE1-CE72-49A7-AAF5-522A333A4358Q34608622-4B0199DD-E3F1-4106-BC94-04DE6D8A7D32Q34678985-BDBAD04C-D792-4488-9AE7-67C47EC0FC31Q35550202-65C91C04-AADB-4FF8-B13E-E96227A27D65Q36337195-8B482BC7-4D12-4649-9AA4-9CEFBF0D518AQ36378600-2D2E202C-AB26-4787-B317-058D84714581Q36449937-0E10AEFF-D622-4498-A6DB-8EDC7852147FQ36788576-3702DB15-578E-43D4-94F6-618E145400F4Q37041973-3F823B69-3A20-42A8-873A-1E88B195B3A8Q37240462-67727582-47E5-469A-B71E-FDE3C4EE1CBAQ37335007-387B411D-053F-4175-9BBC-D6B05384164AQ37421874-40F063A2-F930-4685-A802-8CC8270BD379Q37975995-B0273598-6A5A-41B0-81EC-76E2D57C0A95Q38160496-98DD4422-9749-477D-A3B9-5119B654D496Q38734553-11A68FB9-1C3C-459B-AF0A-33C07D611CF0Q38808009-6ACEC756-C9A8-448B-9238-3D84EBEC1285Q39707623-FAA763C3-6C1B-4B19-82C5-A6642255922AQ39803711-261C4350-D093-4BB3-87CD-0363DE5080F6Q39921715-56D9111D-34FD-449B-AE07-ED986DEDF352Q41901097-C065BA54-961E-403C-94B7-56C96537824FQ42119774-5D6CE6F6-13C4-4576-9ACF-1A433DE31DE2Q42413527-DA7F81DF-FF2F-4373-BE93-3C9A384BDC73Q48139219-65927C39-6EE1-4FDD-9F0D-8948171186D1
P2860
Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Extensive repeat transrectal u ...... vious benign sextant biopsies.
@en
type
label
Extensive repeat transrectal u ...... vious benign sextant biopsies.
@en
prefLabel
Extensive repeat transrectal u ...... vious benign sextant biopsies.
@en
P2093
P1476
Extensive repeat transrectal u ...... vious benign sextant biopsies.
@en
P2093
Borboroglu PG
Riffenburgh RH
P304
P356
10.1097/00005392-200001000-00037
P407
P577
2000-01-01T00:00:00Z